FIELD: medicine.
SUBSTANCE: invention relates to medicine and represents application of dopamine as cytotoxic means for treatment of malignant ascetic tumours.
EFFECT: invention ensures extension of arsenal of means for treatment of malignant ascetic tumours and non-toxic for normal cells and in general for entire organism.
3 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING CYTOTOXIC ACTIVITY ON HUMAN CANCER CELLS IN CULTURE | 2011 |
|
RU2453309C1 |
METHOD FOR MODELING UTERUS BODY TUMOR USABLE FOR INVESTIGATING ITS REGIONAL LYMPH FLOW BED | 2002 |
|
RU2220459C1 |
METHOD FOR MODELING OVARIAN CANCER EXPERIMENTALLY IN RATS | 2020 |
|
RU2743219C1 |
METHOD OF TREATING ASCITIC CARCINOMA | 2015 |
|
RU2595864C1 |
METHOD FOR PREPARING SERUM AGAINST ERLICH TUMOR | 0 |
|
SU563752A1 |
METHOD FOR ERADICATION OF INITIATING CANCER STEM CELLS | 2013 |
|
RU2542410C1 |
ENDOGENIC PHARMACEUTICAL COMPOSITION PREPARED ON BASIS OF GOAL-SEEKING ACTIVATION OF HUMORAL MEDIATORS OF BRAIN CORTEX NERVE ENDING | 2003 |
|
RU2244928C2 |
METHOD OF INHIBITING TUMOUR GROWTH IN MAMMAL | 2018 |
|
RU2713153C1 |
OCTA-4,5-CARBOXYLIC ACID PHTHALOCYANINE COBALT ESTERS, THEIR INCLUSION COMPLEXES WITH BETA-CYCLODEXTRIN PROPYLENE GLYCOL ESTER AND METHOD OF SUPPRESSION OF TUMOR GROWTH | 2000 |
|
RU2172319C1 |
METHOD OF DESTROYING TUMOR ASCITES CELLS USING MAGNETIC NANODISCS AND APTAMERS IN CONDITIONS OF ALTERNATING ELECTROMAGNETIC FIELD | 2023 |
|
RU2814394C1 |
Authors
Dates
2012-10-27—Published
2011-10-12—Filed